Felsher Lab In the Division of Oncology

Clinical Trials

We are pleased to provide you with a summary of some of the most exciting work we are currently pursuing that we closer to better treatments for cancer:

NEW CLINICAL STUDY


Dean Felsher and Alice Fan are spearheading a new clinical study to interrogate the potential therapeutic role of statins, drugs used to treat high cholesterol, for the treatment of lymphoma. If you are interested in participating in this study please contact either:

Alice Fan MD, Co-investigator at 650-736-8655/ afan@stanford.edu
Richa Rajwanshi MD, Study Coordinator at 650-736-8655/ richar@stanford.edu

ANGIOGENESIS AND TARGETED THERAPIES

The Felsher laboratory has recently made a surprising observation that the inactivation of a cancer gene results in the regression of tumors in part by shutting off production of blood vessels that the tumor uses to feed itself (angiogenesis). These results appeared in a manuscript recently published in the Proceedings of the National Academy of Science.

Cancer Gene ON
Cancer Gene OFF
Many Tumor Blood Vessels (red)
Less Vessels to Feed the Tumor

 

NANODIAGNOSTICS

Dr. Alice Fan has been working with Cell Biosciences to develop a powerful new approach for the diagnosis of cancer. Our results were recently highlighted in the press release at the American Society of Cell Biology Meeting.


Taking the measure of mouse and human to identify oncoproteins through nano-fluidic capillaries.

To learn more about the Felsher Laboratory online:
http://med.stanford.edu/labs/dean_felsher/

Recent Press Releases

If you are interested in supporting our clinical research activities please consider sending a gift to:

Dr. Dean W. Felsher, c/o Phyllis Bussey
Division of Oncology, 269 Campus Drive
Stanford, CAA 94305-5151.
Please specify on the check that the funds are to go to the Felsher Gift Fund

Stanford Medicine Resources:

Footer Links: